SOLNA, Sweden--(BUSINESS WIRE)--Regulatory News: Aerocrine AB (STO:AERO-B) announces today that Japanese health authorities have approved the use of its FeNO-measuring device NIOX MINO® as a tool for assessing patients with airway inflammation such as asthma.
Help employers find you! Check out all the jobs and post your resume.
